S

Sinil Pharmaceutical Co Ltd
KOSDAQ:012790

Watchlist Manager
Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
Watchlist
Price: 6 250 KRW Market Closed
Market Cap: 74.9B KRW

Wall Street
Price Targets

Price Targets Summary
Sinil Pharmaceutical Co Ltd

There are no price targets for Sinil Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sinil Pharmaceutical Co Ltd Competitors:
Price Targets
CRON
Cronos Group Inc
37% Upside
688578
Shanghai Allist Pharmaceuticals Co Ltd
12% Upside
ACB
Aurora Cannabis Inc
31% Upside
PFE
Pfizer Inc
17% Upside
2070
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
11% Upside
ERIS
Eris Lifesciences Ltd
19% Upside
293480
Hana Pharm Co Ltd
39% Upside
MANKIND
Mankind Pharma Ltd
23% Upside

Revenue
Forecast

Revenue Estimate
Sinil Pharmaceutical Co Ltd

For the last 13 years the compound annual growth rate for Sinil Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 8 years is -7%.

8%
Past Growth
-7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Sinil Pharmaceutical Co Ltd

For the last 13 years the compound annual growth rate for Sinil Pharmaceutical Co Ltd's operating income is 12%. The projected CAGR for the next 8 years is -3%.

12%
Past Growth
-3%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Sinil Pharmaceutical Co Ltd

For the last 13 years the compound annual growth rate for Sinil Pharmaceutical Co Ltd's net income is 12%. The projected CAGR for the next 8 years is -4%.

12%
Past Growth
-4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Sinil Pharmaceutical Co Ltd's stock price target?
Not Available

Sinil Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Sinil Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-7%

For the last 13 years the compound annual growth rate for Sinil Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 8 years is -7%.

What is Sinil Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-3%

For the last 13 years the compound annual growth rate for Sinil Pharmaceutical Co Ltd's operating income is 12%. The projected CAGR for the next 8 years is -3%.

What is Sinil Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-4%

For the last 13 years the compound annual growth rate for Sinil Pharmaceutical Co Ltd's net income is 12%. The projected CAGR for the next 8 years is -4%.

Back to Top